FI854604A0 - Onkostatiini-A:n käyttö diagnostisessa menetelmässä - Google Patents

Onkostatiini-A:n käyttö diagnostisessa menetelmässä

Info

Publication number
FI854604A0
FI854604A0 FI854604A FI854604A FI854604A0 FI 854604 A0 FI854604 A0 FI 854604A0 FI 854604 A FI854604 A FI 854604A FI 854604 A FI854604 A FI 854604A FI 854604 A0 FI854604 A0 FI 854604A0
Authority
FI
Finland
Prior art keywords
oncostatin
diagnostic procedure
src
induce
synthesized
Prior art date
Application number
FI854604A
Other languages
English (en)
Swedish (sv)
Other versions
FI854604A (fi
FI92258C (fi
FI92258B (fi
Inventor
Daniel R Twardzik
George J Todaro
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/592,969 external-priority patent/US4590003A/en
Application filed by Oncogen filed Critical Oncogen
Publication of FI854604A publication Critical patent/FI854604A/fi
Publication of FI854604A0 publication Critical patent/FI854604A0/fi
Priority to FI940457A priority Critical patent/FI940457A0/fi
Application granted granted Critical
Publication of FI92258B publication Critical patent/FI92258B/fi
Publication of FI92258C publication Critical patent/FI92258C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI854604A 1984-03-23 1985-11-21 Onkostatiini-A:n käyttö diagnostisessa menetelmässä FI92258C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI940457A FI940457A0 (fi) 1984-03-23 1994-01-31 Menetelmä onkostatiini-A:n valmistamiseksi

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US06/592,969 US4590003A (en) 1984-03-23 1984-03-23 Platelet related growth regulator
US59296984 1984-03-23
US06/712,302 US4645828A (en) 1984-03-23 1985-03-15 Platelet related growth regulator
US71230285 1985-03-15
PCT/US1985/000480 WO1985004397A1 (en) 1984-03-23 1985-03-19 Platelet related growth regulator
US8500480 1985-03-19

Publications (4)

Publication Number Publication Date
FI854604A FI854604A (fi) 1985-11-21
FI854604A0 true FI854604A0 (fi) 1985-11-21
FI92258B FI92258B (fi) 1994-06-30
FI92258C FI92258C (fi) 1994-10-10

Family

ID=27081584

Family Applications (1)

Application Number Title Priority Date Filing Date
FI854604A FI92258C (fi) 1984-03-23 1985-11-21 Onkostatiini-A:n käyttö diagnostisessa menetelmässä

Country Status (10)

Country Link
US (1) US4645828A (fi)
EP (1) EP0176588B1 (fi)
JP (2) JPH0632631B2 (fi)
AT (1) ATE107662T1 (fi)
AU (1) AU587380B2 (fi)
DE (1) DE3587863T2 (fi)
DK (1) DK172463B1 (fi)
FI (1) FI92258C (fi)
HU (1) HU210662B (fi)
WO (1) WO1985004397A1 (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294172B1 (en) 1983-08-12 2001-09-25 Dade Behring Marburg Gmbh Monoclonal antibodies with specificity for membrane-associated antigens
US5248666A (en) * 1984-03-23 1993-09-28 Oncogen Methods for inhibiting neoplastic cell proliferation using platelet factor 4
EP0487116B1 (en) * 1984-10-12 1999-12-29 ZymoGenetics, Inc. Biologically active PDGF analogs in eucaryotic cells
US5498600A (en) * 1984-10-12 1996-03-12 Zymogenetics, Inc. Biologically active mosaic proteins
US5187263A (en) * 1984-10-12 1993-02-16 Zymogenetics, Inc. Expression of biologically active PDGE analogs in eucaryotic cells
US4889919A (en) * 1986-08-13 1989-12-26 Zymogenetics, Inc. Biologically active PDGF derived A-chain homodimers
US4766073A (en) * 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US5045633A (en) * 1985-02-25 1991-09-03 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
ATE76311T1 (de) 1986-08-19 1992-06-15 Genentech Inc Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen.
AU623589B2 (en) * 1987-03-02 1992-05-21 Bristol-Myers Squibb Company Platelet related growth regulator
JPH0739489B2 (ja) * 1987-03-06 1995-05-01 東ソー株式会社 ポリアリ−レンスルフイドの製造方法
US5026639A (en) * 1988-01-14 1991-06-25 Nippon Mining Company, Limited Method to improve mRNA translation and use thereof for production of platelet factor-4
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5800820A (en) * 1989-01-10 1998-09-01 Repligen Corporation Methods and compositions for treatment of angiogenic diseases
US5187075A (en) * 1989-01-26 1993-02-16 Sri International Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses
DE3909799A1 (de) 1989-03-24 1990-09-27 Behringwerke Ag Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
US5112946A (en) * 1989-07-06 1992-05-12 Repligen Corporation Modified pf4 compositions and methods of use
IT1239065B (it) * 1990-05-14 1993-09-20 Fidia Spa Anticorpo monoclonale che inibisce l'azione biologica del fattore piastrinico 4
US5648340A (en) * 1991-10-31 1997-07-15 Barnea; Eytan R. Gestational agents for controlling cell proliferation
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
ATE164167T1 (de) * 1990-12-21 1998-04-15 Curative Tech Inc Angiogene peptide
FR2671487B1 (fr) * 1991-01-14 1993-03-19 Oreal Utilisation d'un facteur de croissance dans une composition amincissante.
US5543318A (en) * 1991-06-12 1996-08-06 Smith; David A. Method of isolation, culture and proliferation of human atrial myocytes
AU3592593A (en) * 1992-01-16 1993-08-03 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
JPH08501085A (ja) * 1992-08-26 1996-02-06 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗腫瘍剤としてのサイトカインｉｐ−１０の利用
US5304542A (en) * 1992-08-28 1994-04-19 University Of Louisville Research Foundation, Inc. Use of platelet factor 4 to inhibit osteoblast proliferation
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4
AU7209594A (en) * 1993-06-18 1995-01-17 David F. Counts Anti-inflammatory peptides
US6444421B1 (en) * 1997-11-19 2002-09-03 The United States Of America As Represented By The Department Of Health And Human Services Methods for detecting intermolecular interactions in vivo and in vitro
EP2355847A1 (en) 2008-10-07 2011-08-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (pf4v1)
EP2287183A1 (en) 2009-07-29 2011-02-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Mutants PF4 polypeptides exhibiting an increased anti-angiogenic activity
WO2012101125A1 (en) 2011-01-24 2012-08-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Specific antibodies against human cxcl4 and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3766162A (en) 1971-08-24 1973-10-16 Hoffmann La Roche Barbituric acid antigens and antibodies specific therefor
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
RO80052B (ro) * 1977-11-08 1985-03-30 Genetech Procedeu pentru prepararea unui vehicul recombinat de clonare pentru transformarea unei gazde bacteriene pentru a deveni generator de polipeptida heterologa
US4233402A (en) 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
EP0176588A4 (en) 1989-11-23
AU4235485A (en) 1985-11-01
EP0176588B1 (en) 1994-06-22
AU587380B2 (en) 1989-08-17
EP0176588A1 (en) 1986-04-09
US4645828A (en) 1987-02-24
DE3587863T2 (de) 1994-10-27
FI854604A (fi) 1985-11-21
FI92258C (fi) 1994-10-10
ATE107662T1 (de) 1994-07-15
JPH0242985A (ja) 1990-02-13
DK540685D0 (da) 1985-11-22
DK172463B1 (da) 1998-08-31
JPH0272896A (ja) 1990-03-13
HU210662B (en) 1995-06-28
WO1985004397A1 (en) 1985-10-10
FI92258B (fi) 1994-06-30
DK540685A (da) 1985-11-22
JPH0632631B2 (ja) 1994-05-02
HUT38300A (en) 1986-05-28
DE3587863D1 (de) 1994-07-28

Similar Documents

Publication Publication Date Title
FI854604A0 (fi) Onkostatiini-A:n käyttö diagnostisessa menetelmässä
FI885031A0 (fi) Vaextregulator av blodplaettetyp.
DE3860043D1 (de) Verwendung von biertreberextrakt zur herstellung von medizinischen und kosmetischen zubereitungen.
ZA896468B (en) Lyophilization of red blood cells
IL82890A0 (en) Acellular red blood cell substitute
HK160895A (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
ES8609365A1 (es) Un factor estimulante de colonias (csf)
DE3789781D1 (de) Antigene, Antikörper und Verfahren zur Identifizierung humaner metastatischer Tumoren und Zellinien zur Herstellung dieser Antikörper.
AU555699B2 (en) Pp13 protein from placenta
DE69030494D1 (de) Karzinomverwandtes haptoglobin (hpr)
IT1172216B (it) Procentimento e mezzi per la rivelazione immunologica di cellule cance rose nei campioni di tessuti umani
AR227907A1 (es) Un procedimiento para obtener relaxina humana,por cultivo"in vitro"de tejidos o celulas de decidua
ATE74761T1 (de) Verwendung von pflanzenpollenextrakten zur herstellung von das wachstum von tumorzellen hemmenden pharmazeutischen praeparaten und verfahren zu ihrer herstellung.
DK360186A (da) Diagnostisk fremgangsmaade til bedoemmelse af kliniske parametre ved direkte samling af biologiske materialer, og organ til udfoerelse af fremgangsmaaden
NO169819C (no) Fremgangsmaate for fremstilling av hybrid polypeptid og dna-molekyl for bruk i denne
EP0261648A3 (en) Cell membrane proteins, compositions containing them and procedure for their preparation
AU617330B2 (en) Human papillomavirus type 41, its DNA and the proteins encoded therefrom
IT8767940A0 (it) Procedimento microbiologico per lapreparazione di 9 alfa -idrossi4-androstene-3,17 dione
EP0136093A3 (en) Anti-cancer factors
IL78880A0 (en) Process for producing colorants derived from carrot cell tissue cultures and compositions containing said colorants
NO881942D0 (no) Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten.
GB2197872B (en) Protein derived from the suprabasal cells of the epidermis
ZA876738B (en) Polypeptide related compounds,compositions and test kits useful for the alleviation,treatment and diagnosis of autoimmune diseases
Gattegno et al. Effect of fungizone on phagocytosis of human senescent red blood cells by autologous monocytes in culture.
Clit Psychotic disorders of open heart surgery patients.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: ONCOGEN